KCNE2

Across TCGA pan-cancer cohorts, KCNE2 Mutation is linked to patient survival in 4 of 34 cancer types, making it a survival-associated KCNE2 data layer compared with 25 for mass-spec protein.

The strongest signal is observed in cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), where higher KCNE2 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated KCNE2 expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

CESC, STAD, and SKCM are the cancer types where KCNE2 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CESC	OS	Median	All	0.252	0.800	.002	24	view →
STAD	DFS	Median	All	0.118	0.657	<.001	18	view →
SKCM	DFS	Median	All	0.192	0.757	.022	6	view →
UCEC	DFS	Median	All	1.000	0.632	.049	2	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

KCNE2–CESC (OS)

Open the CESC breakdown →